H.R. 5853 · 112th Congress

Gray Market Drug Reform and Transparency Act of 2012

Stage
In committee
Introduced
2012-05-22
Latest action
2012-05-25 · Referred to the Subcommittee on Health.

Subjects

Administrative law and regulatory procedures
Health
User charges and fees
Department of Health and Human Services
Government information and archives
Prescription drugs
Retail and wholesale trades
Drug safety, medical device, and laboratory regulation
Food and Drug Administration (FDA)
Business records